NY-AQARA
27.2.2024 14:01:39 CET | Business Wire | Press release
Aqara, a leading provider of smart home solutions, is excited to initiate the crowdfunding campaign for its latest home access solution, the Smart Lock U200, on Kickstarter. Designed for flexibility, convenience and security, the U200 lock is built upon the latest Thread protocol and natively Matter-enabled, aiming for effortless integration with the widest range of smart home devices across systems and brands1.
At its core, the Aqara U200 utilizes modern engineering crafted to provide users with numerous secure access options, ranging from fingerprints, one-time and recurring PIN codes, remote access via mobile apps, voice assistant commands to Aqara NFC cards and physical keys. Aqara is also working to add the HomeKey support to the U200 lock, which allows iOS users to unlock by simply tapping a compatible iPhone and Apple Watch. The U200 will be one of the first Matter-compatible locks to support HomeKey unlocking, and the Aqara team is sparing no time on developing and testing before delivering the optimized experiences2.
The U200 features a retrofit design, allowing for hassle-free installation on existing doors - without the need for extensive modification or renovation. Compatible with most doors in both Europe and North America, it attaches to existing lock mechanisms such as European cylinders (emergency function required) and deadbolts using one of the provided adapters3. The U200 intends to bring the modern keyless lifestyle to a broad array of homeowners and renters, while preserving the option to use traditional keys. Users also enjoy easy access sharing, remote access control, and real-time lock status updates for enhanced convenience and security.
The U200 lock runs on rechargeable Li-Ion batteries, while its wireless keypad can either be powered by a pack of four AAA batteries or wired to the existing doorbell wire (12V-24V DC power supply). Thanks to the power-efficient Thread protocol, the U200 lock features a battery life of up to 6 months between each charge4. Moreover, the wireless keypad boasts an IPX5 rating and withstands extreme heat and cold (-18℃/0℉ to 66℃/151℉), ensuring endurance under any climate.
As an integral part of a connected home, the U200 smart lock seamlessly works with other smart home accessories, allowing users to create a fully automated and customized smart home experience. For example, to disarm the home security system automatically when the U200 is unlocked by a family member, or to activate the indoor camera and the video doorbell after consecutive failed attempts to unlock the door. With three color options available for pre-order on Kickstarter, the U200 can fit into most home decor, making it the perfect addition to any home.
The Aqara Smart Lock U200 is now available for pre-order on Kickstarter at https://www.kickstarter.com/projects/aqara-u200/smartlock for those looking to be among the first to explore the latest in home access technologies.
- The U200 can be paired to the Aqara Home app using Bluetooth or the upcoming Aqara Hub M3. Compatibility with third-party Matter-enabled platforms (e.g., Amazon Alexa, Apple Home, Google Home, Samsung SmartThings, Home Assistant) is expected to roll out in waves, and may not be available by the shipment of pre-ordered units.
- HomeKey unlocking support is currently under development, and is expected to become available via a subsequent OTA update after the lock receives certain certification.
- Limitation applies. Please check the Kickstarter page or consult Aqara support for detailed guidelines on the U200 lock compatibility.
- The 6-month battery life is based on the assumption of 8 cycles of fingerprint/NFC unlocking and locking per day.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240227373928/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Netceed Strengthens Board with Global Infrastructure and Technology Leaders1.4.2026 14:00:00 CEST | Press release
Netceed, a global leader in delivering supply chain solutions across broadband, data center and energy infrastructure, today announced the appointment of Franck Bruel, Jan Frykhammar and Stacey Thompson to advise as strategic advisors to its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260401045867/en/ Franck Bruel Following the recently announced recapitalization of the Netceed Group and under the chairmanship of Rajeev Suri, the company is strengthening its Board with globally recognized leaders across telecommunications infrastructure, industrial distribution, energy infrastructure and hyperscale technology. Collectively, the new appointees bring decades of leadership experience across some of the world’s most influential infrastructure and technology companies, reflecting Netceed’s ambition to play a leading role in the next generation of global digital, AI and energy infrastructure. Rajeev Suri, Ch
Vertex Announces US FDA Approval for Label Extensions of ALYFTREK® and TRIKAFTA®, Expanding Availability of These Medicines to ~95% of All People With CF in the United States1.4.2026 13:30:00 CEST | Press release
-With this expansion, any variant that results in production of CFTR protein is now included in the indication for ALYFTREK and TRIKAFTA, reinforcing the impact these medicines have, regardless of the location of the variant in the CFTR protein--Approximately 800 more people with CF in the US are now eligible for a CFTR modulator for the first time- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved expanded use of ALYFTREK® (vanzacaftor/tezacaftor/ivacaftor) for the treatment of people with cystic fibrosis (CF) ages 6 and older with a variant in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is either responsive based on clinical and/or in vitro data or results in production of CFTR protein. Additionally, the U.S. FDA has also expanded the indication statement for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in patients ages 2 and older. This label expansion was supported b
Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer1.4.2026 13:30:00 CEST | Press release
A Landmark Registrational Study Aiming to Redefine Outcomes in MSS mCRC Which Represents Approximately 95% of Metastatic Colorectal Cancer CasesColorectal Cancer Has Become the Leading Cause of Cancer-related Death in Adults Under Age 50 Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that the first patient has been enrolled in the landmark global phase 3 BATTMAN (CO.33) trial (NCT07152821). This study is evaluating Agenus’ immunotherapy combination of botensilimab (BOT) plus balstilimab (BAL) versus best supportive care in patients with refractory, unresectable microsatellite stable (MSS)/mismatch repair proficient (pMMR) metastatic colorectal cancer (mCRC), a population long considered resistant to immunotherapy. This study is being conducted as a cooperative group trial led by the Canadian Cancer Trials Group (CCTG) from Canada and run across Canada, France, Australia and New Zealand. More than 100 sites will participate across the academic cooper
Klarna Agrees to $1.7 Billion Transaction Supporting up to $40B+ of Lending1.4.2026 13:19:00 CEST | Press release
Klarna, the global digital bank and flexible payments provider, has entered into a new capital efficiency transaction in the form of a Significant Risk Transfer (SRT), covering $1.7 billion-worth of Euro denominated loans and freeing up capital to support continued growth. Klarna has entered into a three-year agreement with a consortium led by Värde Partners. This is Klarna's sixth SRT transaction and improves how effectively Klarna deploys its capital on a global basis. "Our banking license is one of our biggest competitive advantages," said Niclas Neglén, Klarna's Chief Financial Officer. "This is our largest and most efficient SRT transaction to date. These transactions allow us to maximize every unit of capital to support our continued momentum." The transaction follows Klarna’s recently announced $2 billion facility supporting $17B of US Financing expansion. About Klarna Klarna is a global digital bank and flexible payments provider. With over 118 million global active Klarna user
Americhem Launches nDryve™: PFAS-Free In-Melt Technology Platform for Functional Fibers1.4.2026 13:00:00 CEST | Press release
Americhem, Inc., a global polymer solutions provider, today announced the launch of nDryve™, a PFAS-free, in-melt surface-modifying technology platform designed to deliver durable multi-fluid repellency against alcohol and other low-surface-energy fluids in fiber systems. As global regulations accelerate the phase-out of per- and polyfluoroalkyl substances (PFAS), manufacturers are under increasing pressure to maintain barrier performance without fluorinated chemistries. nDryve™ was developed to address this shift, offering a PFAS-free, in-melt alternative to conventional surface applied treatments. Engineered for Performance Without PFAS Often referred to as “forever chemicals,” PFAS have come under heightened regulatory scrutiny due to their persistence and potential environmental and health impacts. nDryve™ integrates directly into the polymer during melt processing, embedding surface-modifying functionality within the fiber matrix rather than relying on removable finishes. By engin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom